Click on a filter below to refine your search. Remove a filter to broaden your search.
The ‘Test-to-Treat’ program is part of federal and city efforts to catch and treat infections early and be ready for new waves of the pandemic.
Pfizer and Moderna are expected to start producing reformulated doses this summer.
The director of the NIAID says the drug kept him out of the hospital, however.
The advisory panel approval speeds the process by which FDA regulators will push for updated booster formulations.
<1 percent of patients to whom Paxlovid was dispensed for mild-to-moderate COVID-19 had a hospitalization or emergency department encounter.
Significant associations were seen for concentration and attention, as well as memory issues, with the complaint of brain fog.
The company said Saturday that it was confident that its new booster candidates are better than their predecessor.
Both Pfizer and Moderna have been testing updated booster shots that target the omicron variant.
Substantial protection against hospitalizations and deaths seen among nursing home residents during the omicron surge.
The clinical lexicon presents data elements related to cardiovascular and noncardiovascular complications of COVID-19.